Valeant Pharmaceuticals (VRX) in Focus: Stock Adds 6.9%
Valeant Pharmaceuticals International, Inc. (VRX) was a big mover last session with its shares rising nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above past one month’s volatile price range of $115.48 to $122.15.
This manufacturer of pharmaceuticals, over-the-counter (OTC.TO) products and medical devices has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate has also remained unchanged over the same period. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Valeant Pharmaceuticals currently has a Zacks Rank #5 (Strong Sell) while its Earnings ESP is 0.00%.
Investors interested in the Med-Drugs industry may consider better-ranked stocks like Hyperion Therapeutics (HPTX), Lannett Company, Inc. (LCI) and Endo International plc (ENDP). All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
VALEANT PHARMACEUTICALS INTERNAT (VRX): Free Stock Analysis Report
HYPERION THERAPEUTICS INC (HPTX): Free Stock Analysis Report
LANNETT COMP (LCI): Free Stock Analysis Report
ENDO INTERNATIONAL PLC ORD (ENDP): Free Stock Analysis Report
Zacks Investment Research
